AhR and PPARα:: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11

被引:33
|
作者
Shaban, Z
Soliman, M
El-Shazly, S
El-Bohi, K
Abdelazeez, A
Kehelo, K
Kim, HS
Muzandu, K
Ishizuka, M
Kazusaka, A
Fujita, S
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci,Toxicol Lab, Kita Ku, Sapporo, Hokkaido 0600818, Japan
[2] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Biochem Lab, Sapporo, Hokkaido 0600818, Japan
[3] Tanta Univ, Fac Vet Med, Dept Biochem & Physiol, Tanta, Egypt
关键词
AhR; PPAR alpha; CYP2B; CYP2C11; CYP3A;
D O I
10.1080/00498250400021804
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates a spectrum of toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) and related compounds. The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a member of the nuclear receptor super-family of ligand-activated transcription factors and it functions as an obligate heterodimer with retinoid X-receptor alpha RXR alpha. The aim was to investigate whether the negative cross-talk recently proposed by the present authors between AhR and PPAR alpha on CYP4A and CYP1A has any impact on other cytochrome P450 enzymes. Treatment of male Wistar rats with a PPAR alpha ligand clofibric acid (CA) induced CYP2B1/2 and CYP3A proteins, activities, and the mRNA expression of CYP2B1, CYP2B2, CYP3A1 and CYP3A2, and suppressed CYP2C11 protein, activities and mRNA expression. AhR ligand Sudan III (S.III) treatment decreased basal and CA-induced CYP2B, CYP3A and CYP2C11 protein, activities and mRNA expression. To the best of the authors' knowledge, this is the first study showing the presence of mutual effects of AhR and PPAR alpha on CYP2B and CYP3A and an additive inhibitory effect on CYP2C11 in the livers of male rats.
引用
收藏
页码:51 / 68
页数:18
相关论文
共 50 条
  • [31] The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters
    Huan, JY
    Miranda, CL
    Buhler, DR
    Cheeke, PR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 151 (02) : 229 - 235
  • [32] Quantitative structure-activity relationship study of binding affinity of azole compounds with CYP2B and CYP3A
    Itokawa, Daisuke
    Nishioka, Tomoki
    Fukushima, Junji
    Yasuda, Tomoyo
    Yamauchi, Aiko
    Chuman, Hiroshi
    QSAR & COMBINATORIAL SCIENCE, 2007, 26 (07): : 828 - 836
  • [33] The role of the JAK-STAT pathway in the suppression of CYP3A2 and CYP2C11 by cyclosporine
    Lu, SK
    Callahan, SM
    Croyle, MA
    Brunner, LJ
    DRUG METABOLISM REVIEWS, 2004, 36 : 282 - 282
  • [34] Acute inflammation selectively downregulates the contents and activities of liver CYP2B1, CYP2C6, and CYP2C11 in rats
    Projean, D
    Dautrey, S
    Ducharme, J
    DRUG METABOLISM REVIEWS, 2003, 35 : 82 - 82
  • [35] Effects of Paeonia emodi on hepatic cytochrome P450 (CYP3A2 and CYP2C11) expression and pharmacokinetics of carbamazepine in rats
    Raish, Mohammad
    Ahmad, Ajaz
    Alkharfy, Khalid M.
    Jan, Basit L.
    Mohsin, Kazi
    Ahad, Abdul
    Al-Jenoobi, Fahad I.
    Al-Mohizea, Abdullah M.
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 90 : 694 - 698
  • [36] Fast LC-MS/MS method for determination of CYP1A, CYP2B and CYP3A induction in primary human hepatocytes
    Palacios, Mary A.
    Frank, Karl B.
    Moore, David J.
    DRUG METABOLISM REVIEWS, 2009, 41 : 86 - 87
  • [37] Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat
    Vecera, Rostislav
    Zacharova, Alice
    Orolin, Jan
    Strojil, Jan
    Skottova, Nina
    Anzenbacher, Pavel
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2011, 32 (08) : 482 - 487
  • [38] Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin
    Lu, SK
    Callahan, SA
    Jin, RY
    Brunner, LJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) : 215 - 224
  • [39] Influence of dietary zinc deficiency during development on hepatic CYP2C11, CYP2C12, CYP3A2, CYP3A9, and CYP3A18 expression in postpubertal male rats
    Xu, ZM
    Kawai, M
    Bandiera, SM
    Chang, TKH
    BIOCHEMICAL PHARMACOLOGY, 2001, 62 (09) : 1283 - 1291
  • [40] Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen
    Kawai, M
    Bandiera, SM
    Chang, TKH
    Poulet, FM
    Vancutsem, PM
    Bellward, GD
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (12) : 1392 - 1398